Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

We recently published 10 Shares Explode as Earnings Impress. Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the ...

IO Biotech’s off-the-shelf cancer vaccine shows promise in melanoma with key data ahead, but funding risk limits near-term ...

Symvess (acellular tissue engineered vessel-tyod) was approved in the extremity vascular trauma indication by the Food and Drug Administration (FDA) in December 2024.

Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...

Industries are embracing these geometric shapes, which were imagined in 1970 by a NASA scientist. Decades later, they have ...

John Burke, MD, discusses his editor-in-chief column from the July 2025 issue of Targeted Therapies in Oncology.

Jyong Biotech targets urinary disorders with a novel botanical pipeline, but clinical and liquidity risks temper near-term ...

Would you dab perfume on a six-month-old? Paint their tiny nails with polish that contains formaldehyde? Dust bronzer onto their cheeks? An ...

As we have explained previously, there are notable aspects of continuity between President Trump’s AI policy and that of former President Biden’s. Both have, for example, sought to spur growth and ...

Despite regulatory setbacks, the petitioners believe that survival and other data they've collected themselves are worth ...

Tumors of the central nervous system (CNS) are the most common pediatric tumor type and the leading cause of cancer-related ...